Hawkeye Systems Announces Letter of Intent to Secure Three-Year FDA Approved Nitrile Glove Supply

PR Newswire

SAVANNAH, Ga., Nov. 12, 2020 /PRNewswire/ — Hawkeye Systems, Inc. (OTCQB: HWKE)(“Company”), a technology holding company focused on pandemic management products and services, is pleased to announce today it has signed a Letter of Intent (LOI) with Whistler International Korea, a leading multinational conglomerate located in Seoul with operations in Asia, Middle East and Latin American Countries. Under the terms of the LOI, the Company is expected to secure a three-year FDA approved Nitrile glove supply comprised of 3,600,000 boxes annually.   

Corby Marshall, CEO of Hawkeye Systems, stated, “We are pleased to continue positioning the Company to procure dedicated supply sources of mission critical PPE (Personal Protective Equipment) as the number of COVID-19 positive cases continues to resurge in the US. We believe our LOI with Whistler to provide highly coveted Nitrile protective gloves further validates Hawkeye as a reliable PPE source with an established track record that already includes the previously announced procurement and delivery of FDA approved hand sanitizer and N95 protective masks. We value the process of safety and are honored to leverage our ability to navigate both international and domestic trade lines to strengthen our Country’s pandemic response.”

About Hawkeye Systems, Inc.

Hawkeye Systems, Inc. is a technology holding company focused on cutting edge technology, pandemic management products and services. The Company is committed to leveraging its extensive resources in support of its ongoing mission to help our government and medical infrastructure keep civilians safe.

For more information, please contact:
Corby Marshall, CEO
Number: +1 (800) 531-8799
Email: [email protected] 
Website: hawkeyesystemsinc.com 
Investor relations –  [email protected]

Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to the body camera system, the potential success of the body camera system, our growth strategy and product development including PPE, any technology related to our sales pipeline, and any other statements that are not historical facts. Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: risks related to our growth strategy; risks relating to the results of research and development activities; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our dependence on third-party suppliers and partners; our ability to attract, integrate, and retain key personnel; the early stage of products under development; our need for substantial additional funds; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. Important factors that may cause the actual results to differ from those expressed within may include, but are not limited to: the success or failure of Hawkeye’s efforts to successfully market its products and services as scheduled; Hawkeye’s ability to attract and retain quality employees; the effect of changing economic conditions; increased competition; the ability of Hawkeye to obtain adequate debt or equity financing. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.

 

 

Cision View original content:http://www.prnewswire.com/news-releases/hawkeye-systems-announces-letter-of-intent-to-secure-three-year-fda-approved-nitrile-glove-supply-301171730.html

SOURCE Hawkeye Systems, Inc.

Venzee Announces MercadoLibre Integration Enabling Brands to Connect with 320 Million Consumers Using a Single Digital Connection

PR Newswire

Major Latin American Retail Channel Activated for Fortune 500 Hardware Manufacturer

CHICAGO, Nov. 12, 2020 /PRNewswire/ – Venzee Technologies Inc. (TSXV: VENZ) (“Venzee” or the “Company”) today announced activation and initial client use of a Venzee Mesh Connector™ for MercadoLibre (NASDAQ: MELI) – a leading e-commerce destination for consumers across 18 Latin American countries.

Using the Venzee platform, brands and manufacturers set up a single digital connection that allows selection of an unlimited number of Mesh Connectors™ to feed critical data and product information to global retailers.

According to Peter Montross, EVP Commercial Operations for Venzee, “Our team prioritized development of a MercadoLibre connector at the request of a Fortune 500 consumer tool brand looking to expand their global retail footprint without adding labor, time, or complexity. Venzee’s low cost Mesh Connector™ to MercadoLibre – and their retail base of more than 320 million consumers – fit that need.”

Venzee’s proprietary Mesh Connector™ technology automatically adapts and conforms to diverse retail requirements – enabling brands to reduce labor, reduce cost, and expand their global retail sales and distribution channels.

Chad Kaczmarek, Senior Director of Integrations at Venzee said, “To sell a product, brands have a choice – they can set up thousands of individual retail connections manually, using teams of people, or they can use Venzee and configure a single connection to endlessly expand their retail sales channels using our Mesh Connector™ technology. If retail scale and speed are important, Venzee is the obvious choice.”

Venzee has previously announced 327 Retail Channels available for selection through the Company’s platform. The Company has recently added five new retail channels and will continue to grow connections as they are requested by brands and partners utilizing the Venzee platform. Across 14 active Fortune 500 client engagements, the Company currently has more than 412 Mesh Connector™ opportunities.

Said Mr. Montross, “Activation of the MercadoLibre connection validates our position as the most efficient path large brands can take to accelerate sales – in regional or global consumer markets. We expect hundreds of additional brands looking to connect with more than 300 million consumers in Latin America will leverage our Mesh Connector™ to MercadoLibre over the next year.”

In line with the Company’s operational business model, brands compensate the Company for use of the MercadoLibre Mesh Connector™ at various contracted rates. MercadoLibre requires the Company to meet various technical and operational criteria but does not compensate the Company.

Separately, the Company has announced settlement of an outstanding debt in the amount of CAD$12,000 by issuing an aggregate of 133,333 common shares (the “Debt Shares”) at a deemed price of $0.09 per share. The Debt Shares will have a 4-month hold period and the debt settlement is subject to the approval of the TSX Venture Exchange.

About Mercado Libre, Inc.

MercadoLibre (NASDAQ: MELI) is an Argentine company incorporated in the United States and is the leading e-commerce company in Latin America.

Through its six integrated ecommerce platforms including MercadoLibre, MercadoPago and MercadoEnvíos, it offers technology solutions that enable companies and individuals to buy, sell, announce, send and pay for goods and services over the internet.

MercadoLibre is among the top 50 most visited websites in the world in terms of page views, and it is the ecommerce platform with the most unique visitors in each country where it operates.

About Venzee Technologies, Inc.

Venzee (TSX-V VENZ) is a technology platform used by Global Brands to speed products to market and create competitive supply chain advantage. Venzee displaces costly, labor-intensive last-mile retail processes with a low-cost intelligent platform solution.

We believe intelligent supply chain functionality is inevitable and will significantly benefit growers, makers, brands, sellers, regulators, and consumers. At Venzee, we’re building the foundation for a future where seamless, accurate, automated data flow simplifies processes, removes friction, and creates value for all those that rely on the myriad of data and information surrounding any product, anywhere.

Venzee’s mission is to unlock shareholder value by creating intelligent technology that removes friction from the global supply chain. Our products disrupt and displace inefficient manual processes in favor of integrated, machine-driven solutions.

Rethinking Supply Chain Podcast

Now available on Apple, Spotify, and other Podcast services, Venzee CEO, John Abrams, shares his expertise from years of work in the global supply chain – alongside other industry experts. On the show, we dive into all aspects of the supply chain. We discuss the history of the supply chain, how it is changing, and what makes for a resilient supply network in today’s rapidly changing world.

To learn more about Venzee, visit venzee.com

On Behalf of the Board,

John Sexton Abrams

President and CEO
Venzee Technologies, Inc.
[email protected]
888-359-9299

Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the terms of the Offering, the completion of the Offering and the expected use of the net proceeds received by the Company. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to: general business, economic, competitive, geopolitical and social uncertainties; and regulatory risks. Additional information about these assumptions and risks and uncertainties is contained under “Risk Factors and Uncertainties” in the Company’s management’s discussion and analysis for the year ended December 31, 2018, and the quarter ended August 29, 2019, which are available under the Company’s SEDAR profile at www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future.

Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information contained in this news release is expressly qualified in its entirety by this cautionary statement.

The Company does not undertake to update any forward-looking information, except as required by applicable securities laws.

Neither TSX-V nor its Regulation Services Provider (as that term is defined in policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/venzee-announces-mercadolibre-integration-enabling-brands-to-connect-with-320-million-consumers-using-a-single-digital-connection-301171412.html

SOURCE Venzee Technologies Inc.

Dr. Lisa Costa, Chief Information Officer at U.S. Special Operations Command and Advisor to Fortune 500 Companies, Joins CarParts.com Board of Directors

Dr. Lisa Costa, Chief Information Officer at U.S. Special Operations Command and Advisor to Fortune 500 Companies, Joins CarParts.com Board of Directors

Dr. Costa will provide big data, cyber, and tech expertise to growing e-commerce company

TORRANCE, Calif.–(BUSINESS WIRE)–CarParts.com, Inc. (NASDAQ: PRTS) (“CarParts.com”), announced today that Dr. Lisa Costa, Chief Information Officer of the U.S. Military’s Special Operations Command (USSOCOM), joins the CarParts.com Board of Directors. As a leading cybersecurity and data analytics experts, she will provide valuable guidance and insights into how both the company and its customers can stay ahead of online threats while utilizing information to better serve customers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201112005404/en/

Dr. Lisa Costa, Chief Information Officer at U.S. Special Operations Command and Advisor to Fortune 500 Companies, Joins CarParts.com Board of Directors (Photo: Business Wire)

Dr. Lisa Costa, Chief Information Officer at U.S. Special Operations Command and Advisor to Fortune 500 Companies, Joins CarParts.com Board of Directors (Photo: Business Wire)

“We are honored to have Dr. Costa join the board,” said CarParts.com CEO Lev Peker. “With her deep understanding of business, technology, and eCommerce, as well as success in advising Fortune 500 companies, Dr. Costa is an incredible and invaluable addition to the team. Her guidance and expertise will be key, and we’re confident that both our customers and our company will greatly benefit from her joining the board.”

CarParts.com COO David Meniane is particularly excited about Dr. Costa’s expertise in data analytics. “The companies that will win the future will be the companies that can marshal all available information to create terrific experiences for their customers – to deliver services that truly serve their customers’ needs,” said Meniane. “Dr. Costa’s expertise in data analytics will yield vital insights for CarParts.com, insights that will help us provide the best service for our customers.”

In addition to serving as CIO for USSOCOM – where she oversees a $1.2 billion budget and an IT system including cloud infrastructure, mobility, satellite and terrestrial communications, and DevSeCops agile software development supporting artificial intelligence and machine learning – Dr. Costa was a member of multiple Defense Science Boards, invented the first fully spherical immersive digital video system, and has advised Presidential Transition Teams on national security issues. She served on the board of Hire Our Heroes and has advised Fortune 500 companies, including Target, Hilton, Starbucks, Cheniere, and FedEx, on data analytics and cybersecurity. She is also an honoree of the James Schlesinger Award for Service to Our Nation.

“I am excited to be joining the CarParts.com Board of Directors,” said Dr. Costa. “CarParts.com was born online – its entire history is in the ecommerce space, the same space that so many other companies are struggling to enter. For 25 years, it has stayed true to its ecommerce lineage. It is a relentless innovator and puts technology first. I am thrilled to lend my expertise to the company as it continues to grow, and as it sprints towards the countless opportunities it sees.”

About CarParts.com

For over 25 years, CarParts.com has been a leader in the e-commerce automotive aftermarket, providing collision, engine, and performance parts and accessories. With over 50 million parts delivered, we’ve helped everyday drivers across the continental United States find the right parts to keep their vehicles on the road.

With a focus on the end-to-end customer experience, we’ve designed our website and sourcing network to simplify the way drivers get the parts they need. Our vehicle selector and easy-to-navigate, mobile-friendly website offers customers guaranteed fitment and a convenient online shopping experience. And with our own wide distribution network, we bring the very best brands and manufacturers directly to consumer hands, cutting out all the brick-and-mortar supply chain costs to provide quality parts at a discount for our loyal customers. Combined with our 90-day return policy and satisfaction guarantee, CarParts.com makes it simple for customers to get parts delivered straight to their door.

CarParts.com is headquartered in Torrance, California.

Media Contact:

Sasha Trosman

[email protected]

Investor Contact:

Ryan Lockwoood

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Online Retail Other Retail Consumer General Automotive Technology Automotive Other Manufacturing Retail Women Automotive Manufacturing Other Technology Manufacturing

MEDIA:

Logo
Logo
Photo
Photo
Dr. Lisa Costa, Chief Information Officer at U.S. Special Operations Command and Advisor to Fortune 500 Companies, Joins CarParts.com Board of Directors (Photo: Business Wire)

Allscripts Client Experience Event Connects Thousands of Attendees Virtually From Around the World

Allscripts Client Experience Event Connects Thousands of Attendees Virtually From Around the World

Company provided more than 135 online sessions, sharing 60 hours of content and raising funds to support efforts to end child hunger

CHICAGO–(BUSINESS WIRE)–
Allscripts (NASDAQ: MDRX) hosted its 2020 Allscripts Client Experience (ACE) last month, bringing together thousands of the company’s valued clients, strategic partners, associates and Health IT leaders from around the world to discuss industry drivers and trends that impact healthcare organizations today and help prepare them for tomorrow. The virtual conference was the largest-attended ACE in the company’s history, welcoming eleven times the average number of clients who typically participate in the event. Users across all core Allscripts EHR platforms (as well as hundreds currently not using core EHR solutions) from the United States, Canada, United Kingdom and Australia attended the conference. Attendees gained insights into key issues shaping the healthcare industry in 2020, including the COVID-19 pandemic and its permanent impact on care delivery.

Clinicians had the opportunity to speak with and hear from an impressive collection of industry thought leaders. During one highly attended session, Dr. Marcus Plescia from the Association of State and Territorial Health Officers (ASTHO), Dr. Emily Gurley from the Johns Hopkins Bloomberg School of Public Health and Dr. Dave Swerdlow from Pfizer discussed the timely topics of COVID-19 testing, contact tracing and vaccine development.

“We’re really going to depend on all of you who are involved in diagnosing and testing for COVID-19 to help us make sure we have good systems to report on COVID results,” Dr. Plescia told Allscripts clients during the panel.

“Getting in touch and being knowledgeable about your local public health response is really useful. Many public health departments have made materials available and have them translated into languages that may be useful. Pointing them to the right resources and having them available if you are seeing patients in real time is a great step to take,” Dr. Gurley said.

In addition, clients shared their successes with Allscripts solutions and the value ACE brought to their organizations.

Faith Thompson, MSN RN, RN Clinical Analyst, Clinical Informatics, Hendrick Health shared the power of a full perioperative solution in Allscripts Sunrise™. “Allscripts allows us to integrate all of our surgery systems in a seamless effort,” she said. “We have access to all the critical information, located in one place, in one system. One Patient. One Chart.”

Dr. Jeeny Job, Chief Medical Informatics Officer at St. Barnabas stated how imperative Allscripts patient portal is to its organization. “The FollowMyHealth® solution already had clinical information for patients to access, whether it was the clinical summary of visits, pharmacy information, medication information, or opportunities to secure messages from providers after visits,” she said. “These were all areas of opportunities and value for patients. We thought that adding the video option to the portal as your access to providers created more value to our patients. In just one month, the number of transactions was over 1,600, a huge leap in adoption. The biggest driver of that is the adoption we had for behavioral health patient population. We’ve been really pleased with the adoption so far and we’re increasing those transactions every day.”

Mark Hutchinson, of Gloucestershire Hospitals NHS Foundation Trust in the U.K., discussed the benefits that Allscripts Sunrise provides. “When we were laying the tracks of the system that would take us from a low maturity score to HIMSS Level 6, we knew we had a proven, tried and tested solution with Allscripts’ EPR. It was a flexible system that allowed us to build what we needed ourselves, while being confident that it would always work for us.”

Melissa Huff, Chief Information Officer at Clinics of North Texas, shared how the Allscripts Revenue Cycle Management was the best solution for her organization’s needs. “When looking into a revenue cycle services company that could help us, we had several come on site to discuss,” she said. The Allscripts Revenue Cycle Management staff offered the best product, for the best pricing, and was able to understand our processes right from the start. When Allscripts took over our revenue cycle initiatives they simply hit the ground running. She added, “Working with Allscripts is a true partnership. There is not a day that goes by where we don’t speak to our Revenue Cycle Management Services team. We know that at any time needed, we have a dedicated team we can reach out to. Our collections have increased by 3%. Our payments per encounter have increased. I am frequently asked if I could go back would I engage with Allscripts again. My answer: absolutely, yes! If you asked anybody in our organization I think everyone would tell you we should have made the change much sooner.”

Carol Bahner, from University Hospitals in Cleveland shared her experience at ACE. “What we loved the most about ACE this year was discussing the latest solutions, roadmaps and updates. ACE education content struck just the right balance between focusing on the products and inspiring the health-IT community. The sessions were interactive and provided the latest insights from fellow industry experts.”

Jill Helm of Veradigm participated in a Surescripts sponsored education session entitled, “Medication Cost Conversation – What’s the Hold Up?” The session covered the concept of prescription price transparency (PPT) and how Veradigm’s RxTruePrice solution enables physicians to have the difficult but needed conversation on prescription costs right at the point of prescribing. One session attendee remarked, “Excellent session about PPT and how to implement in real-life practice.”

No Kid Hungry Partnership for GiveBack Initiative

The World Health Organization estimates that by the end of 2020, the pandemic will have caused chronic hunger to increase by approximately 20% globally. During virtual ACE 2020, Allscripts partnered with No Kid Hungry, raising funds to support chronic hunger.

“Allscripts was honored to host thousands of our clients and healthcare thought leaders from around the world for our flagship event, hosted for the first time in a completely virtual environment,” said Allscripts CEO Paul Black. “Bringing together healthcare leaders from various sectors of our industry—especially during such a crucial, challenging time for global healthcare delivery—created engaging discussions that were informative, thought-provoking and inspiring. We look forward to building upon this year’s event with an even more successful ACE in 2021.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTubeand The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Investors:

Stephen Shulstein

312-386-6735

[email protected]

Media:

Concetta Rasiarmos

312-447-2466

[email protected]

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: General Health Health Data Management Technology Software

MEDIA:

Logo
Logo

Leatt Corp Announces Third Quarter 2020 Results

Revenues increase 18% to $11.4 million; net income increases 22% to $1.6 million

Best Third Quarter in Company History

PR Newswire

CAPE TOWN, South Africa, Nov. 12, 2020 /PRNewswire/ — Leatt Corporation (OTCQB: LEAT), a leading developer and marketer of protective equipment and ancillary products for many forms of sports, especially extreme high-velocity sports, today announced financial results for the third quarter ending September 30, 2020. All financial numbers are in U.S. dollars.

Financial and Business Highlights for the Third Quarter

  • Global revenues increased by 18%, to $11.4 million compared to the 2019 third quarter
  • U.S. revenues increased 47% compared to the 2019 third quarter
  • Net income increased 22% to $1.6 million compared to the 2019 third quarter
  • Strong revenue growth fueled by continued investment in “Head-to-Toe” brand delivery

Financial and Business Highlights Year to Date

  • Year to date revenues increased 23% to $25.9 million compared to nine-month period of 2019
  • Year to date net income increased 89% to $2.6 million compared to nine-month period of 2019
  • Continued strong cost control while revenues continue to grow

CEO Sean Macdonald commented: “We had yet another ground-breaking quarter, the best third quarter in our history in terms of revenue and profitability. Global revenues were $11.4 million, up 18% over the third quarter of 2019.  In the U.S., our most important market, revenues grew by a remarkable 47% over last year, driven by fantastic demand for our innovative protective gear from MOTO dealers, MTB dealers and ultimately end consumers who continue to participate strongly in outdoor activities, despite the turmoil caused by the global COVID pandemic.

“For the first nine-months of 2020, revenues were $25.9 million, an increase of $4.8 million or 23%, when compared to the comparative nine-month period. We are building a larger and more professional sales organization in both the MOTO and MTB areas, particularly in the United States where we believe we have the ability to reach more dealers around the country. Leatt as a “head to toe” brand has become an important revenue driver for more dealers – a trend that we are investing in.

“We saw break out revenue growth in our footwear, now consisting of Mountain biking shoes and Motorcycle boots, and our expanding line of body armor and goggle product categories. Although overall helmet sales were down slightly, we believe that our investment in re-engineering our helmet line will contribute to significant returns in the future in light of encouraging initial industry reviews, athlete feedback and consumer demand for our completely re-engineered line of MOTO helmets.”

Founder and Chairman, Dr. Christopher Leatt, remarked: “We are very proud of our new range of 2021 MTB and MOTO riding gear and apparel, including new helmets, jackets, gloves, pants, shorts and jerseys. All our products are engineered and designed by our in-house team and tested in the field by our professional riders. Along with style, what you see in these products are the kinds of technological advancements in terms of comfort, safety, and quality Leatt is known for around the world.

Financial Summary for Third Quarter 2020

Total revenues for the three-month period ended September 30, 2020 were $11.4 million, up 18%, compared to $9.6 million for the 2019 third quarter.

The increase in revenues for the third quarter was driven by a 76% increase in sales of other products, parts and accessories, and a 25% increase in body armor sales, that were partially offset by a 5% decrease in helmet sales, and a 39% decrease in neck brace sales due to orders that were placed during the initial phase of the COVID-19 pandemic.  Those conservative buying patterns are expected to normalize over the next several quarters. Neck brace sales continue to generate a higher gross profit margin than our other product categories.

For the third quarter of 2020, gross profit was $4.9 million, or 44% of revenues, compared to $4.5 million, or 47% of revenues, for the third quarter of 2019.

Total operating expenses were $2.9 million, up 4%, compared to $2.8 million for the third quarter of 2019.

Net income for the three months ended September 30, 2020 was $1.6 million, or $0.27 per diluted share, up 22%, compared to $1.3 million, or $0.24 per diluted share, for the third quarter of 2019.

Leatt continued to meet its working capital needs from cash on hand and internally generated cash flow from operations.  Cash increased by 38%, as compared to cash on hand at December 31, 2019.  At September 30, 2020, the Company had cash and cash equivalents of $2.9 million, and a current ratio of 2.5:1.

Business Outlook

Mr. Macdonald said. “Although our business model continues to show strength, we are cautiously monitoring consumer buying trends during the COVID-19 pandemic to plan for any economic turbulence and industry headwinds that may arise. 

“But based on our promising results to date in 2020, we are optimistic. We have worked hard to adjust to the new challenges brought on by the pandemic. Along with our larger and more professional sales and marketing team, we have focused on e-commerce and creating a new website that is much simpler for customers to navigate and make online purchases. 

“We have a strong pipeline of cutting-edge products that will ship to our customers globally over the next several quarters.  Recent launches of goggles, boots and other exceptional protective gear and now our MTB shoe and MOTO boot line have earned very positive reviews for performance in the field and very encouraging consumer demand levels. We believe that our portfolio of products defines Leatt as a premium ‘Head-to-Toe brand’ and are a testament to our team’s ability to develop a full offering of innovative products that appeal to a wide rider audience.

“We continue to redefine our product offerings and our market share potential in a majority of the new categories in which we compete.  Our strong operating cashflow will be re-invested in our growth engine – developing innovative, cutting edge products – as well as in building our global consumer brand and refining our sales channels.”

Conference Call

The Company will host a conference call on Thursday, November 12, 2020 at 10:00 AM ET to discuss the 2020 third quarter results.

Participants should dial in to the call ten minutes before the scheduled time, using the following numbers: 1-877-407-9716 (U.S.A) or 1-201-493-6779 (international) to access the call.

Audio Webcast

There will also be a simultaneous live webcast through the Company’s website, www.leatt-corp.com. Participants should register on the website approximately ten minutes prior to the start of the webcast.

Replay

An audio replay of the conference call will be available for seven days and can be accessed by dialing 1-844-512-2921 (U.S.A) or +1-412-317-6671 (international).  Enter conference ID # 13712961.

For those unable to attend the call, a recording of the live webcast, will be archived shortly following the event for 30 days on the Company’s website.

About Leatt Corp

Leatt Corporation develops personal protective equipment and ancillary products for all forms of sports, especially extreme motor sports. The Leatt-Brace® is an award-winning neck brace system considered the gold standard for neck protection for anyone wearing a crash helmet as a form of protection. It was designed for participants in extreme sports or riding motorcycles, bicycles, mountain bicycles, all-terrain vehicles, snowmobiles and other vehicles. For more information, visit www.leatt.com. 

Follow Leatt® on FacebookInstagram, and Twitter.

Forward-looking Statements:

This press release contains forward-looking statements regarding Leatt Corporation (the “Company”) within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.  All statements, other than statements of historical fact included herein are “forward-looking statements” including statements regarding: the likelihood that end consumer engagement in outdoor activities like riding
during the Covid-19 pandemic
will continue to drive customer buying trends; the likelihoodthatthe Company willbe able tocontinue its development and introduction of cutting-edge products or be able to ship such products to customers globally in future quarters during the Covid-19 pandemic; the likelihood that the Company will continue to develop its e-commerce capabilities to benefit from the increase in customer e-commerce buying patterns during the pandemic, or that the Company will continue to achieve strong revenue growth in domestic and international markets; the financial outlook of the Company; the general ability of the Company to achieve its commercial objectives, especially in view of the ongoing global pandemic; the business strategy, plans and objectives of the Company and its subsidiaries; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “seeks,” “should,” “could,” “intends,” or “projects” or similar expressions, and involve known and unknown risks and uncertainties. These statements are based upon the Company’s current expectations and speak only as of the date hereof. Any indication of the merits of a claim does not necessarily mean the claim will prevail at trial or otherwise. Financial performance in one period does not necessarily mean continued or better performance in the future. The Company’s actual results in any endeavor could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, which factors or uncertainties could be beyond our ability to foresee or control. Other risk factors include the status of the Company’s common stock as a “penny stock” and those listed in other reports posted on The OTC Markets Group, Inc.

* FINANCIAL TABLES*

 


LEATT CORPORATION


CONSOLIDATED BALANCE SHEETS


ASSETS


September 30, 2020


December 31, 2019


Unaudited


Audited

Current Assets

  Cash and cash equivalents

$              2,868,661

$             2,072,864

  Short-term investments

58,255

58,239

  Accounts receivable

5,620,541

2,956,012

  Inventory

6,872,164

8,655,176

  Payments in advance

904,573

447,476

  Prepaid expenses and other current assets

1,848,486

1,129,067

    Total current assets

18,172,680

15,318,834

Property and equipment, net 

2,461,093

2,431,061

Operating lease right-of-use assets, net

254,066

411,956

Other Assets

  Deposits

32,591

26,642

   Total other assets

32,591

26,642

Total Assets

$            20,920,430

$           18,188,493


LIABILITIES AND STOCKHOLDERS’ EQUITY

Current Liabilities

   Accounts payable and accrued expenses

$              6,007,857

$             5,425,681

   Note payable to bank

100,000

300,000

   Operating lease liabilities, current

163,858

190,765

   Income tax payable

859,609

592,661

   Short term loan, net of finance charges

71,897

576,474

      Total current liabilities

7,203,221

7,085,581

Paycheck Protection Program loan

210,732

Deferred Compensation

220,000

160,000

Operating lease liabilities, net of current portion

90,208

221,191

Commitments and contingencies

Stockholders’ Equity

   Preferred stock, $.001 par value, 1,120,000 shares

     authorized, 120,000 shares issued and outstanding

3,000

3,000

   Common stock, $.001 par value, 28,000,000 shares

     authorized, 5,386,723 shares issued and outstanding

130,068

130,068

   Additional paid – in capital

8,145,716

8,079,774

   Accumulated other comprehensive loss

(768,851)

(529,045)

   Retained earnings

5,686,336

3,037,924

      Total stockholders’ equity

13,196,269

10,721,721

Total Liabilities and Stockholders’ Equity

$            20,920,430

$           18,188,493

 


LEATT CORPORATION


CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME


Three Months Ended


Nine Months Ended


September 30


September 30


2020


2019


2020


2019


Unaudited


Unaudited


Unaudited


Unaudited

Revenues

$ 11,370,946

$ 9,649,335

$ 25,855,950

$ 21,017,329

Cost of Revenues

6,422,472

5,152,688

14,129,516

11,027,944

Gross Profit

4,948,474

4,496,647

11,726,434

9,989,385

Product Royalty Income

36,016

17,360

40,675

33,056

Operating Expenses

   Salaries and wages

784,131

739,366

2,251,583

2,330,006

   Commissions and consulting
   expenses

157,672

104,608

345,014

263,168

   Professional fees 

181,233

133,480

716,138

518,017

   Advertising and marketing

543,020

520,633

1,524,251

1,556,515

   Office lease and expenses

78,932

71,725

225,132

210,263

   Research and development
   costs

404,723

357,258

1,129,535

1,063,573

   Bad debt expense

32,172

148,685

59,092

158,184

   General and administrative
   expenses

459,993

485,054

1,390,236

1,473,708

   Depreciation 

212,564

191,712

595,365

569,707

       Total operating expenses

2,854,440

2,752,521

8,236,346

8,143,141

Income from Operations

2,130,050

1,761,486

3,530,763

1,879,300

Other Income (expenses)

   Interest and other expenses,
   net

19,727

(449)

1,621

(4,042)

      Total other income (expenses)

19,727

(449)

1,621

(4,042)

Income Before Income Taxes

2,149,777

1,761,037

3,532,384

1,875,258

Income Taxes

538,320

440,259

883,972

471,542

Net Income Available to Common Shareholders

$   1,611,457

$ 1,320,778

$   2,648,412

$   1,403,716

Net Income per Common Share

   Basic

$            0.30

$          0.25

$            0.49

$            0.26

   Diluted

$            0.27

$          0.24

$            0.45

$            0.25

Weighted Average Number of Common Shares Outstanding

   Basic

5,386,723

5,386,723

5,386,723

5,384,753

   Diluted

5,860,428

5,532,275

5,860,428

5,530,304

Comprehensive Income

    Net Income

$   1,611,457

$ 1,320,778

$   2,648,412

$   1,403,716

    Other comprehensive income, net of $-0- and $-0- deferred
    i

ncome taxes in 2020 and 2019

       Foreign currency translation 

17,584

(102,756)

(239,806)

(69,591)

       Total Comprehensive Income

$   1,629,041

$ 1,218,022

$   2,408,606

$   1,334,125

 


LEATT CORPORATION


CONSOLIDATED STATEMENTS OF CASH FLOWS


FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2020 AND 2019


2020


2019

Cash flows from operating activities

   Net income 

$ 2,648,412

$ 1,403,716

   Adjustments to reconcile net income to net cash provided by 

     operating activities:

     Depreciation 

595,365

569,707

     Stock-based compensation

65,942

166,250

     Bad debts reserve

47,639

137,787

     Inventory reserve

(9,002)

35,248

     Gain on sale of property and equipment

(25,046)

(1,500)

    (Increase) decrease in: 

       Accounts receivable

(2,712,168)

(3,916,510)

       Inventory

1,792,014

(2,188,013)

       Payments in advance

(457,097)

(94)

       Prepaid expenses and other current assets

(719,419)

221,279

       Deposits

(5,949)

(787)

    Increase (decrease) in:

       Accounts payable and accrued expenses

582,176

4,151,748

       Income taxes payable 

266,948

358,814

       Deferred compensation

60,000

60,000

          Net cash provided by operating activities

2,129,815

997,645

Cash flows from investing activities

    Capital expenditures

(697,625)

(616,278)

    Proceeds from sale of property and equipment

25,745

10,000

    Increase in short-term investments, net

(16)

(4)

          Net cash used in investing activities

(671,896)

(606,282)

Cash flows from financing activities

    Issuance of common stock

15,000


    Proceeds (repayment) of note payable to bank, net

(200,000)

350,000

    Proceeds from Paycheck Protection Program loan

210,732

    Repayments of short-term loan, net

(504,577)

(509,019)

          Net cash used in financing activities

(493,845)

(144,019)

Effect of exchange rates on cash and cash equivalents

(168,277)

(50,632)

Net increase in cash and cash equivalents

795,797

196,712

Cash and cash  equivalents – beginning of period

2,072,864

1,709,900

Cash and cash equivalents – end of period

$ 2,868,661

$ 1,906,612

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

  Cash paid for interest

$      26,446

$      16,509

  Cash paid for income taxes

$    616,148

$    111,600

  Other noncash investing and financing activities

    Common stock issued for services

$      65,942

$    166,250

 

Cision View original content:http://www.prnewswire.com/news-releases/leatt-corp-announces-third-quarter-2020-results-301171650.html

SOURCE Leatt Corporation

BNY Mellon’s MarginConnect Completes Non-Cleared Derivatives Workflow for Buy-Side

PR Newswire

NEW YORK, Nov. 12, 2020 /PRNewswire/ — Buy-side investment managers are now able to take full control over the collateralization of non-cleared derivatives following the introduction of MarginConnect, BNY Mellon’s new margin messaging capability.

Utilizing MarginConnect, managers who wish to retain control over the collateralization of their non-cleared derivatives activity can now do so, leveraging a direct connection between AcadiaSoft and BNY Mellon.

Until now, buy-side derivatives users traditionally have not been able to keep management of their non-cleared OTC collateral entirely in-house. This is because instructions to move collateral assets among custodians typically rely upon SWIFT messaging.

The vast majority of buy-side entities do not have a SWIFT network membership, meaning that they have had to either build and maintain their own connectivity to their custodian or outsource the messaging component instructing the actual movement of collateral to a SWIFT member.

MarginConnect addresses this gap in the workflow by enabling managers to bypass the costs associated with the SWIFT network by sending messages via BNY Mellon’s MarginConnect offering, which is fully integrated into the AcadiaSoft platform.

Utilizing this link, clients are able to generate collateral instructions within the AcadiaSoft ecosystem without having to separately create and deliver SWIFT messages or log into their BNY Mellon triparty or third-party collateral account.

“MarginConnect will enable those newly in-scope clients that wish to keep control of their own collateral management under the next two phases of the non-cleared margin rules to do precisely that: maintain control,” says Dominick Falco, Head of Collateral Segregation at BNY Mellon. “Being the first collateral manager to fully integrate our messaging with AcadiaSoft means that our clients will be able to seamlessly communicate with BNY Mellon and trade counterparties without having to rely on an intermediary.”

“AcadiaSoft is continually striving for workflow automation and cost efficiency; integrating our industry-standard messaging platform into MarginConnect provides the next step on this journey toward zero-touch processing. We are excited to play a central role in helping our mutual clients benefit from a seamless workflow in the non-cleared derivatives space and furthering our partnership with BNY Mellon,” says Mark Demo, Head of Community Development at AcadiaSoft.

MarginConnect’s straight-through processing can also reduce operational risk by eliminating the need to manually enter messaging details, since trade calculations are auto-generated within the platform.

In May 2019, BNY Mellon and AcadiaSoft unveiled a comprehensive collateral administration service that provides a fully outsourced solution for buy-side firms seeking to comply with the non-cleared margin rules. MarginConnect complements that end-to-end offering with a cost-effective alternative, enabling those market participants with the capability to manage their own collateral processes to conduct their own margin calculation and messaging.

ABOUT BNY MELLON
BNY Mellon is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment life cycle. Whether providing financial services for institutions, corporations or individual investors, BNY Mellon delivers informed investment and wealth management and investment services in 35 countries. As of September 30, 2020, BNY Mellon had $38.6 trillion in assets under custody and/or administration, and $2.0 trillion in assets under management. BNY Mellon can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute or restructure investments. BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK). Additional information is available on www.bnymellon.com. Follow us on Twitter @BNYMellon or visit our newsroom at www.bnymellon.com/newsroom for the latest company news.

ABOUT ACADIASOFT
AcadiaSoft, Inc. is the leading industry provider of risk and collateral management services for the non-cleared derivatives community. AcadiaPlus is a new-generation open platform that provides the sell-side, the buy-side and fund administrators with specialist applications and a third-party partner ecosystem for the straight-through processing of the entire risk mitigation life cycle. Backed by 16 major industry participants and market infrastructures, AcadiaSoft is used by a community of more than 1,350 firms exchanging approximately $700B of collateral on a daily basis via its margin automation services. AcadiaSoft is headquartered in Norwell, MA, and has offices in London, New York and Tokyo. For more information, visit acadiasoft.com.

Contact:  

Peter Madigan        
BNY Mellon                              
[email protected]
+1 212 815 2308                                                     

Laura Craft

AcadiaSoft                   
[email protected]
+44 20 3954 0196  

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bny-mellons-marginconnect-completes-non-cleared-derivatives-workflow-for-buy-side-301171093.html

SOURCE BNY Mellon

Landsea Homes Launches Interactive Virtual Experience For High Performance Homes Program

Elevated and Innovative Virtual Experience Allows Homebuyers to Visualize the High Performance Homes Program Features

PR Newswire

NEWPORT BEACH, Calif., Nov. 12, 2020 /PRNewswire/ — Landsea Homes, a Newport Beach-based homebuilder, has launched a new High Performance Homes (HPH) interactive experience. The new program allows homebuyers to visualize and virtually experience every element and feature of the HPH program, from home automation to sustainability and energy savings.

“Long before our homes are built, forward thinking goes into every design detail,” said Peter Beucke, vice president of sustainability and innovation at Landsea Homes. “As a leader in the industry, our homes are designed to the highest standard, and we want our buyers to be able to experience that advantage before they even set foot in their new home. With the new HPH interactive experience, we’re giving buyers an elevated and innovative virtual glimpse into how much healthier, safer and more comfortable their home will be.”  

All of Landsea Homes’ High Performance Homes are more connected and convenient than ever. Supported by a partnership with leading technology company, Apple®, the homes utilize the Apple HomeKit™ environment to operate all home automation features from one mobile application. The smart home automation features, installed and compatible with Apple HomeKit™, include an Apple TV® media manager device, MeshNet wireless internet throughout the home, entry door locks, thermostat control, garage door opener control, light dimmer switches, doorbell camera pre-wire and high-touch customer service with an individualized white glove training session.

Landsea Homes includes various features that contribute to healthy living, including appliances that reduce energy waste and tankless water heaters that generate hot water in a faster timeframe. The use of environmentally-conscious building materials and the implementation of waste-reduction programs help preserve and protect the beauty of the natural world and lessen the impact on the planet.

With each High Performance Home, the homebuyer is provided with enhanced insulation, more efficient mechanical systems, ENERGY STAR® rated appliances and LED lighting. The cost-in-use features lower monthly bills and encourages environmental awareness and stewardship.

For over five years, Landsea Homes has positioned itself as a leader in new-home innovation and technology that is committed to sustainable building practices. A multitude of energy-efficient, sustainable and environmentally-friendly practices were instituted, resulting in a lighter environmental impact, lower resource consumption and reduced carbon footprint.

Landsea Homes has announced plans to merge with LF Capital Acquisition Corp. (NASDAQ: LFAC), which would make Landsea a public company in the fourth quarter of 2020.

For more information, visit https://landseahomes.com/hph.  

About Landsea Homes

Landsea Homes is a California-based homebuilding company that designs and builds best-in-class homes and sustainable master-planned communities in some of the nation’s most desirable markets. The company has developed homes and communities in New York, Boston, New Jersey, Arizona, northern California and southern California.

An award-winning homebuilder that builds suburban, single-family detached and attached homes, mid-and high-rise properties, and master-planned communities, Landsea Homes is known for creating inspired places that reflect modern living and provides homebuyers the opportunity to “Live in Your Element”.  Our homes allow people to live where they want to live, how they want to live – in a home created especially for them. 

Driven by a pioneering commitment to sustainability, Landsea Homes’ Performance collection features homes that are responsibly designed to take advantage of the latest innovations with home automation technology supported by Apple®.  Homes in this collection include features that make life easier and provide energy savings that allow for more comfortable living at a lower cost through sustainability features that contribute to healthier living for both homeowners and the planet. 

Our Garrett-Walker collection offers unique, affordably priced and value-based single-family homes in some of the nation’s fastest growing and most desirable markets. Homebuyers enjoy the confidence of owning a quality home that provides lasting value.  One of the most trusted brands in the region, this collection continues to attract everyone from first-time homeowners to those seeking more room for their growing families.

Led by a veteran team of industry professionals who boast years of worldwide experience and deep local expertise, Landsea Homes is committed to positively enhancing the lives of our homebuyers, employees and stakeholders by creating an unparalleled lifestyle experience that is unmatched.

For more information on Landsea Homes, visit: www.landseahomes.com.  

Cision View original content:http://www.prnewswire.com/news-releases/landsea-homes-launches-interactive-virtual-experience-for-high-performance-homes-program-301171570.html

SOURCE Landsea Homes

SHAREHOLDER ALERT: Nikola Investors with $200,000 or More in Losses Encouraged to Contact Schubert Jonckheer & Kolbe LLP Regarding Their Shareholder Rights

PR Newswire

SAN FRANCISCO, Nov. 12, 2020 /PRNewswire/ — Schubert Jonckheer & Kolbe LLP announces that it has filed a class action lawsuit in the U.S. District Court for the District of Arizona against Nikola Corporation (NASDAQ: NKLA) for violations of the federal securities laws, captioned Eves v. Nikola Corporation, et al., No. 2:20-at-99911. Investors with losses in Nikola stock are encouraged to contact the firm.

Nikola, headquartered in Phoenix, Arizona, describes itself as a designer and manufacturer of zero-emission battery-electric and hydrogen-electric vehicles, electric vehicle drivetrains, vehicle components, energy storage systems, and hydrogen station infrastructure. On September 10, 2020, Hindenburg Research (“Hindenburg”), a company that specializes in forensic financial research, published a scathing report entitled “Nikola: How to Parlay An Ocean of Lies Into a Partnership With the Largest Auto OEM in America.” The Hindenburg report indicated that Hindenburg had gathered “extensive evidence—including recorded phone calls, text messages, private emails and behind-the scenes photographs.” The Hindenburg report represented that it had identified “dozens of false statements by” founder and chairman Trevor Milton.

On this news, the Company’s stock price fell $4.80 per share, or 11.33%, to close at $37.57 per share on September 10, 2020. The stock continued to fall on this news to a September 11, 2020 close of $32.13 per share, a two day drop of approximately 24%.

On September 14, 2020, after the markets had closed, Bloomberg reported that the U.S. Securities and Exchange Commission was investigating Nikola to assess the merits of the Hindenburg report. On September 14, 2020, Nikola issued a response to the Hindenburg report attempting to deny some, but not all, of the allegations. Then, on September 15, 2020, the Wall Street Journal reported that the U.S. Department of Justice was also investigating Nikola. Also on September 15, 2020, Hindenburg released a second report addressing Nikola’s response, including highlighting many of the allegations by Hindenburg that Nikola had failed to dispute.

On this news, Nikola’s stock fell an additional $0.17 per share during intraday trading, to close at $32.83 on September 15, 2020, an 8.27% decline from its previous close on September 14, 2020.

The Schubert Firm is investigating legal claims for shareholder losses. For more information, please visit our website at http://www.classactionlawyers.com/Nikola. If you suffered $200,000 or more in losses in Nikola stock and wish to obtain additional information about shareholder claims and your legal rights, please contact us today.

About Schubert Jonckheer & Kolbe

Schubert Jonckheer & Kolbe represents shareholders, employees, and consumers in class actions against corporate defendants, as well as shareholders in derivative actions against their officers and directors. The firm is based in San Francisco, and with the help of co-counsel, litigates cases nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Willem F. Jonckheer

Schubert Jonckheer & Kolbe LLP
[email protected] 
Tel: 415-788-4220

 

Cision View original content:http://www.prnewswire.com/news-releases/shareholder-alert-nikola-investors-with-200-000-or-more-in-losses-encouraged-to-contact-schubert-jonckheer–kolbe-llp-regarding-their-shareholder-rights-301171572.html

SOURCE Schubert Jonckheer & Kolbe LLP

Bed Bath & Beyond® Unveils New Cozy Backyard Holiday Collection To Help Customers Celebrate Traditions With A Twist This Winter

Decorist Design Inspiration Will Help Customers ‘Enjoy the Present’ by Creating a Winter Wonderland at Home

PR Newswire

UNION, N.J., Nov. 12, 2020 /PRNewswire/ — Bed Bath & Beyond® (NASDAQ: BBBY) unveiled a new Cozy Backyard Holiday collection today, curated to inspire customers to ‘enjoy the present’ with ideas to create a winter wonderland at home. The Cozy Backyard Holiday collection created by our design team at Decorist will offer a curated assortment of furnishings and décor, expert tips, and design inspiration for families to safely celebrate traditions with a twist by entertaining outdoors this holiday season.  

Bed Bath & Beyond is the destination to unlock the magic in every room both inside and outside the home. This year, outdoor living spaces have been a place of solace to spend socially distanced time with friends and family and our recently commissioned market research shows that nearly a quarter (23%) of Americans are planning to celebrate the holidays outdoors this year. 1 We have also seen a significant rise in demand for outdoor furniture, heating and lighting, including over a 100% increase in customer searches for firepits in October from our digital store. In October, pinners searching for “outdoor Thanksgiving” increased by 139% on Pinterest compared to the same period in 2019.

Cindy Davis, Executive Vice President and Chief Brand Officer of Bed Bath & Beyond and President of Decorist said, “At a time when our homes are the epicenter of our lives, outdoor living spaces have been an important place to enjoy time with friends and family safely. We know many customers want to extend the outdoor living season through the winter, so they can enjoy traditions with a twist this year. We’ve pivoted quickly to create our Cozy Backyard Holiday collection, with the help of our Decorist designers, to inspire shoppers to find everything they need to warm-up and cozy-up their outdoor spaces this season. We’re also making it faster, safer and easier than ever to shop through our new Buy-Online-Pickup-In-Store, Curbside Pickup and Same Day Delivery services.”

Decorist designer Sarah Ramirez has created a multi-purpose environment with distinct zones for dining and lounging, and offers easy tips for turning your outdoor space into a cozy, cold-weather wonderland:

  • Create Distinct Entertaining Zones: A geometric-pattern outdoor rug is the foundation for the intimate fire pit seating area, which is equipped with all the essentials for a relaxing winter evening: comfy pillows, knitted throws, elegant hurricane lanterns, and baskets filled with firewood. Beyond it, a dining table and chairs with a transitional slatted design look just as handsome outdoors as they do when seen from inside.
  • Add Some Color and Style: These days you can find a sturdy outdoor rug to fit any style. A simple outdoor rug will define your space while adding extra softness, warmth, and texture.
  • Good Lighting Is Key: Skip the porchlights. Your choice of lighting is crucial for setting the right mood. Nostalgic flameless candles brighten corners and lift spirits. Hang rustic lanterns from branches and use them in tablescapes. Introduce shimmering surprises by tossing jumbles of fairy lights into shrubs, oversize glass vases, and other dark spots. The options are endless—and so Instagrammable.
  • Make It Cozy: Is there anything more luxurious than a warm fleece or wool throw on a cold night? A colorful array of throw blankets brings indoor comfort outside.
  • Fortify Your Oven-to-Table Arsenal: Dutch ovens and other enameled baking dishes that go straight from oven to table are a huge timesaver – both at serving and cleanup time. Plan your menu with festive and gorgeous pieces from Artisanal Kitchen Supply®, Staub, and LeCreuset in mind. If you need to round out your collection with one or two new pieces, consider it a great investment.
  • Make Room: A patio pergola or gazebo makes a great frame for an instant outdoor “room.” Many models include canopies that allow for ventilation while shielding guests from the elements. Note that some of these summer staples aren’t built to bear the weight of snow, so proceed with caution if you live in a snow zone.

The new winter Cozy Backyard Holiday collection is yet another way Bed Bath & Beyond is helping bring a little holiday magic back this season. 

Bed Bath & Beyond is offering inspirational ideas and products with incredible value throughout the holidays on everything from seasonal décor to home essentials or thoughtful gifts. Bed Bath & Beyond will also help customers spend more time celebrating with loved ones this year, with hassle-free, fast and convenient omnichannel shopping services like free Buy-Online-Pickup-In-Store and Curbside Pickup, as well as the newly introduced Same Day Delivery service. The Same Day Delivery service is available at a flat rate fee of $4.99 for orders over $39, providing an easy, convenient and affordable option for customers this year that is perfect for last minute gifts and entertaining essentials.

For more details on Bed Bath & Beyond® holiday savings, visit https://www.bedbathandbeyond.com/.

About Bed Bath & Beyond:
Bed Bath & Beyond Inc. and subsidiaries (the “Company”) is an omnichannel retailer that makes it easy for our customers to feel at home. The Company sells a wide assortment of merchandise in the Home, Baby, Beauty and Wellness markets. Additionally, the Company is a partner in a joint venture which operates retail stores in Mexico under the name Bed Bath & Beyond.

About Decorist:

Decorist is an online interior design company that makes decorating a home easy and affordable. Executed entirely online, Decorist’s roster of over 400 professional interior designers help beautifully design any room in the home, staying within a client’s style and budget. And for customers not ready to start a full design project, they can consult Decorist’s Design Bar to have quick design questions answered by Decorist’s team of interior designers, completely free of charge. The company is a subsidiary of Bed Bath & Beyond Inc. 

1 Based on an online survey of 1,003 people aged 18+ in the United States, conducted by Kelton Global, a Material Company, for Bed Bath & Beyond 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bed-bath–beyond-unveils-new-cozy-backyard-holiday-collection-to-help-customers-celebrate-traditions-with-a-twist-this-winter-301171473.html

SOURCE Bed Bath & Beyond

CNS Pharmaceuticals to Discuss Phase 2 Clinical Trial Design to be Submitted for FDA Review in Webcast at 4:30 PM ET Today

The discussion will be moderated by Robert LeBoyer, Managing Director of Equity Research at Ladenburg Thalmann & Co., Inc.

PR Newswire

HOUSTON, Nov. 12, 2020 /PRNewswire/ — CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced its presentation to discuss the clinical trial design for its upcoming Phase 2 U.S. trial for Berubicin, its lead drug candidate for the treatment of glioblastoma multiforme (GBM), will be available via webcast today at 4:30pm ET. The discussion will be moderated by Robert LeBoyer, Managing Director of Equity Research at Ladenburg Thalmann & Co., Inc.

The Company plans to submit an Investigational New Drug (IND) application to the U.S. Food & Drug Administration (FDA), which includes a novel clinical trial designed to build on the encouraging results observed in a prior Phase 1. The Phase 2 trial will randomize patients to Berubicin or standard of care. This upcoming trial will include interim assessments that will evaluate the comparative safety and effectiveness of these treatments with an adaptive design intended to complete a thorough investigation into Berubicin as expeditiously as possible.


Details of the webcast are below:

Date:                     November 12th, 2020
Time:                     4:30 PM ET
Link:                       https://cnspharma.com/webcast-november-2020/

About CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals, Inc. related to a completed Phase 1 clinical trial with Berubicin in malignant brain tumors, which Reata conducted in 2006. In this trial the overall response rate of stable disease or better was 44%. This 44% disease control rate was based on 11 patients (out of 25 evaluable patients) with stable disease, plus responders. One patient experienced a durable complete response and remains cancer-free as of Feb. 20, 2020. These Phase 1 results represent a limited patient sample size and, while promising, are not a guarantee that similar results will be achieved in subsequent trials. By the end of 2020, CNS expects to commence a Phase 2 clinical trial of Berubicin for the treatment of GBM in the U.S., while a sub-licensee partner undertakes a Phase 2 trial in adults and a first-ever Phase 1 trial in pediatric GBM patients in Poland. Its second drug candidate, WP1244, is a novel DNA binding agent that has shown in preclinical studies that it is 500 times more potent than the chemotherapeutic agent daunorubicin in inhibiting tumor cell proliferation.

For more information, please visit www.CNSPharma.com.

Forward-Looking Statements

Some of the statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the ability of the Company to seek accelerated approval from the FDA of a New Drug Application (NDA) following the planned Berubicin trial. These statements relate to future events, future expectations, plans and prospects. Although CNS believes the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. CNS has attempted to identify forward-looking statements by terminology including ”believes,” ”estimates,” ”anticipates,” ”expects,” ”plans,” ”projects,” ”intends,” ”potential,” ”may,” ”could,” ”might,” ”will,” ”should,” ”approximately” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including those discussed under Item 1A. “Risk Factors” in CNS’s most recently filed Form 10-K filed with the Securities and Exchange Commission (“SEC”) and updated from time to time in its Form 10-Q filings and in its other public filings with the SEC. Any forward-looking statements contained in this press release speak only as of its date. CNS undertakes no obligation to update any forward-looking statements contained in this press release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cns-pharmaceuticals-to-discuss-phase-2-clinical-trial-design-to-be-submitted-for-fda-review-in-webcast-at-430-pm-et-today-301171565.html

SOURCE CNS Pharmaceuticals, Inc.